| NP020502-ABT2535 |
β-Amyloid (25-35)Aβ25-35 | Aβ 25-35 | Abeta25-35 | AB25-35 | Amyloid β-Peptide (25-35) | Amyloid β-Protein (25-35) | Amyloid beta 25-35 | Amyloid beta (25-35) | beta-Amyloid (25-35) | beta-Amyloid peptide (25-35) | β-Amyloid-25-35 | β-Amyloid (25-35) | BetaAPP25-35 | BAPP25-35 | βAPP25-35B | APP25-35 | BAP 25-35 | A-BETA(25-35) | DA-25-35 | Amyloid β Protein Fragment 25-35 |
131602-53-4 |
| β-Amyloid (25-35) is a chemically synthesized human amyloid beta peptide fragment spanning residues 25 to 35. |
| NP020601-ABH42 |
β-Amyloid (1-42) (Human), HClAβ1-42 | Aβ 1-42 | Abeta42 | AB42 | Amyloid β-Peptide (1-42) | Amyloid β-Protein (1-42) | Amyloid beta 1-42 | Amyloid beta (1-42) | beta-Amyloid (1-42) | beta-Amyloid peptide (1-42) | β-Amyloid-42 | β-Amyloid (1-42) | BetaAPP42 | BAPP42 | βAPP42B | APP42 | BAP 1-42 | A-BETA(1-42) | DA-42 | Amyloid β Protein Fragment 1-42 |
107761-42-2 |
| Beta-Amyloid 1-42(Human) HCl is prepared and provided in the form of HCl salt. |
| NP020601-ABT42 |
β-Amyloid (1-42) (Human), TFAAβ1-42 | Aβ 1-42 | Abeta42 | AB42 | Amyloid β-Peptide (1-42) | Amyloid β-Protein (1-42) | Amyloid beta 1-42 | Amyloid beta (1-42) | beta-Amyloid (1-42) | beta-Amyloid peptide (1-42) | β-Amyloid-42 | β-Amyloid (1-42) | BetaAPP42 | BAPP42 | βAPP42B | APP42 | BAP 1-42 | A-BETA(1-42) | DA-42 | Amyloid β Protein Fragment 1-42 |
107761-42-2 |
| β-Amyloid (1-42) (Human) is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease. |
| NP020601-HAB42 |
β-Amyloid 1-42(Human), HFIP-treatedAβ1-42 | Aβ 1-42 | Abeta42 | AB42 | Amyloid β-Peptide (1-42) | Amyloid β-Protein (1-42) | Amyloid beta 1-42 | Amyloid beta (1-42) | beta-Amyloid (1-42) | beta-Amyloid peptide (1-42) | β-Amyloid-42 | β-Amyloid (1-42) | BetaAPP42 | BAPP42 | βAPP42B | APP42 | BAP 1-42 | A-BETA(1-42) | DA-42 | Amyloid β Protein Fragment 1-42 |
107761-42-2 |
| Beta-Amyloid 1-42 (Human), HFIP-treated has been treated with hexafluoroisopropanol (HFIP). |
| NP020602-ABT40 |
β-Amyloid (1-40) (Human)Amyloid beta-protein fragment 1-40;Amyloid β Protein Fragment 1-40;Amyloid β -Protein (1-40); Aβ40; Abeta 40; Abeta 1-40; Aβ1-40 |
131438-79-4 |
| β-Amyloid (1-42) (Human) is a primary protein in plaques found in the brains of patients with Alzheimer's disease. |
| NP020605-ABT42-S |
β-Amyloid (1-42), ScrambledScrambled Aβ1-42, Scrambled Amyloid beta 1-42, β-Amyloid (1-42) scrambled peptide, Aβ 1-42 negative control peptide, Random sequence Aβ1-42, Non-amyloidogenic Aβ1-42 variant, Scrambled beta-amyloid 1-42 control, Aβ1-42 non-aggregating control peptide |
1678415-52-5 |
| Scrambled Beta-Amyloid 1-42 peptide is the sequence-randomized negative control for wild-type human Aβ1-42. |
| NP020607-F-ABT42 |
FITC-beta-Amyloid (1-42)FITC-Aβ1-42 | FITC-Aβ 1-42 | FITC-Abeta42 | FITC-AB42 | Amyloid β-Peptide (1-42) | FITC-Amyloid β-Protein (1-42) | FITC-Amyloid beta 1-42 | FITC-Amyloid beta (1-42) | FITC-beta-Amyloid (1-42) | FITC-beta-Amyloid peptide (1-42) | FITC-β-Amyloid-42 | FITC-β-Amyloid (1-42) | FITC-BetaAPP42 | FITC-BAPP42 | FITC-A-BETA(1-42) | FITC-DA-42 | FITC- Amyloid β Protein Fragment 1-42 |
|
| FITC-beta-Amyloid (1-42) is a peptide in which the FITC fluorophore is conjugated to the N-terminus of Aβ1-42. |
